SOLIS trial demonstrates that spinal cord stimulation (SCS) provides superior, sustained pain relief, function, and quality of life in nonsurgical refractory back pain.
St. Jude Medical has announced that it received FDA 510(k) clearance for the St. Jude Medical Invisible Trial System, which is a mobile-enabled discreet spinal cord stimulation (SCS) trial system.
Medtronic (($MDT)) announced an update on their ongoing clinical study. Study Overview: Medtronic is conducting a study titled Feasibility and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback